Mitochondrial Effects of C18:0 Supplementation in Humans
NCT ID: NCT02957838
Last Updated: 2017-11-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
23 participants
INTERVENTIONAL
2016-11-30
2017-11-18
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Non-diabetics
Non-diabetic volunteers with HbA1c \< 6.5%. Subjects will be treated with C18:0 supplementation or mock.
C18:0
Receives 24g of C18:0 in a low-fat banana milkshake.
mock
Low fat banana milkshake without C18:0 supplement.
Type 2 Diabetics
Type 2 Diabetes according to common definitions, but we exclude insulin-treated Type 2 diabetics because nutritional intervention is more difficult/risky. Subjects will be treated with C18:0 supplementation or mock.
C18:0
Receives 24g of C18:0 in a low-fat banana milkshake.
mock
Low fat banana milkshake without C18:0 supplement.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
C18:0
Receives 24g of C18:0 in a low-fat banana milkshake.
mock
Low fat banana milkshake without C18:0 supplement.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* must be able to give consent
Exclusion Criteria
* severe diseases inducing wasting (e.g. cancer, liver cirrhosis, renal failure)
* conditions of malnourishment
* severe anemia
* pregnancy
* alcohol abuse
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
German Cancer Research Center
OTHER
University Hospital Heidelberg
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Daniel Pfaff
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Peter P Nawroth, MD
Role: STUDY_DIRECTOR
University Hospital Heidelberg
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Heidelberg
Heidelberg, Baden-Wurttemberg, Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Senyilmaz D, Virtue S, Xu X, Tan CY, Griffin JL, Miller AK, Vidal-Puig A, Teleman AA. Regulation of mitochondrial morphology and function by stearoylation of TFR1. Nature. 2015 Sep 3;525(7567):124-8. doi: 10.1038/nature14601. Epub 2015 Jul 27.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
S-675/2015
Identifier Type: -
Identifier Source: org_study_id